Abstract

High-fat, low-carb ketogenic diets have been used around for over a century for the treatment of epilepsy. In recent years, the use of ketogenic diets traditionally used for the treatment of resistant pediatric epilepsies has expanded to include conditions ranging from refractory status epilepticus to febrile infection-related epilepsy syndrome. In such cases where the enteral route can not be used, it may be life-saving to consider the parenteral ketogenic diet. However, there are some points to be considered for proper and effective monitoring by starting this treatment effectively and reliably. The aim of this review is to increase the awareness of physicians and dieticians on this subject in the light of the case reports, studies and international clinical practice guide.